Unlock instant, AI-driven research and patent intelligence for your innovation.

Rapamycin glucoside type compound as well as enzyme method preparation and application thereof

A technology of rapamycin and glucoside, which is applied in the preparation, application, and drug combination of sugar derivatives, and can solve problems such as difficult selective protection, many by-products, and not being environmentally friendly

Inactive Publication Date: 2020-07-07
SHANDONG UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are few reports on the glycosylation modification of rapamycin, limited to the rapamycin glycosides reported by Gantt in 2011 and the rapamycin glycoconjugates chemically synthesized by Moni et al. in 2013, other types Glycosylation products have not been reported and the biological activity of the rapamycin glycoside compounds reported above is unknown
In addition, there are many by-products in chemical synthesis, difficult separation and purification, not environmentally friendly, and difficult to selectively protect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rapamycin glucoside type compound as well as enzyme method preparation and application thereof
  • Rapamycin glucoside type compound as well as enzyme method preparation and application thereof
  • Rapamycin glucoside type compound as well as enzyme method preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1 Expression of glycosyltransferase BsGT-1, in vitro glycosylation reaction, and preparation of rapamycin glucoside

[0042] The inventor screened and identified a glycosyltransferase BsGT-1 (CUB50191) capable of efficiently glycosylating rapamycin, and its protein sequence has been published.

[0043] The recombinant plasmid containing pET28a-BsGT-1 was transformed into Escherichia coli BL21 (DE3), and the resulting transformant was transferred to 2ml of LB medium supplemented with kanamycin (final concentration was 40 μg / ml), 200r / min, at 37 Cultivate at ℃ for 12 hours, then transfer 2ml of the seed solution to 100ml of LB medium (the final concentration of kanamycin is 40μg / ml), and expand the culture at 37℃. When the OD value reaches about 0.6-0.8, add Isopropyl-β-D-thiogalactopyranoside (IPTG) with a final concentration of 0.1 mM, and then transferred to a shaker at 16° C., 200 r / min, cultivated for 24 hours, centrifuged at 8000 r / min for 5 min, and collect...

Embodiment 2

[0048] Example 2 Compound 1, Compound 2 and Compound 3 Structure Identification

[0049] The structures of compound 1, compound 2 and compound 3 were determined by high-resolution mass spectrometry and nuclear magnetic resonance analysis, according to figure 2 and image 3 , UHPLC-ESI-Q-TOF high-resolution mass spectrometry gives compound 1 and compound 2 quasi-molecular ion peaks [M+Na] + They are m / z 1098.5886 and 1098.5913 respectively, thus confirming that 1 and 2 are monoglucosides of rapamycin. Simultaneously, the monosaccharide can also be obtained from the H NMR spectra of compounds 1 and 2 ( 1 H NMR, Figure 5 , Figure 10 ) and carbon spectrum ( 13 C NMR, Figure 6 , Figure 11 ) to be confirmed. Two-dimensional NMR spectroscopy determined the link between the sugars of compounds 1 and 2 and the main chain of rapamycin ( Figure 7-9 , Figure 12-14 ).

[0050] In the HMBC spectrum of compound 1, H-40 is related to C-1' and H-1' is related to C-40, thus co...

Embodiment 3

[0052] Example 3 Antifungal activity test of rapamycin glucoside

[0053] Screening method: half-dilution method

[0054] Cell lines: Candida albicans; Fusarium graminearum and Pythium aphanidermatum

[0055] Action time: 48 hours

[0056] experimental method:

[0057] 1. Use YPD liquid medium (dissolve 10g yeast extract, 20g peptone in 900ml water, high pressure 115°C, 15min, add 100ml 20g glucose) to cultivate Candida albicans, when OD 600 When it reaches 0.3, carry out dilution coating and dilute to 10 5 -10 6 The concentration of cells / ml was used for the antifungal test. The initial drug concentration was set at 32 μg / ml, and half-diluted in a 96-well plate. The inhibition rates of the corresponding concentrations of compounds 1, 2, and 3 were as follows:

[0058] The inhibitory rates of compound 1 to Candida albicans were 96.08% (32 μg / ml), 95.20% (16 μg / ml), 94.75% (8 μg / ml), 94.26% (4 μg / ml), 94.26% (2 μg / ml) , 94.01% (1 μg / ml), 92.83% (0.5 μg / ml), 88.98% (0.25 μ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a rapamycin glucoside type compound which is rapamycin 40-O-beta-D glucoside,rapamycin 28-O-beta-D glucoside or rapamycin 28,40-O-beta-D glucoside. The compound is prepared through a glycosylation reaction mediated by rapamycin and UDP-O-beta-D-glucose and glycosyl transferase BsGT-1. The invention further discloses application of the rapamycin glucoside type compound in preparing a medicine for preventing and treating animal or plant pathogens, liver cancer and breast cancer. Experiments show that the rapamycin glucoside type compound disclosed by the invention has a remarkable antibacterial capability upon candida albicans, fusarium graminearum and pythium aphanidermatum, has antitumor activity approximate to the effect of a rapamycin original medicine (10.70[mu]g / ml and 8.64[mu] g / ml) upon HepG2 liver cancer cells and MCF-7 breast cancer cells, has good water solubility, and has great anti-fungus and antitumor activity application value.

Description

technical field [0001] The present invention relates to a group of rapamycin glycoside compounds and their enzymatic preparation and application, in particular to a group of rapamycin glucoside derivatives and their enzymatic preparation methods, and the rapamycin glucoside derivatives Application in the preparation of medicines for treating and preventing animal and plant pathogenic bacteria, liver cancer and breast cancer. The invention belongs to the technical field of microbial technology and its products and applications. Background technique [0002] Rapamycin (Rapamycin, also known as Sirolimus, Sirolimus) is a nitrogen-containing triene macrolide antibiotic produced by Streptomyces hygroscopicus. It was first found to have good antifungal activity. In 1999 In September, the FDA approved it as an immunosuppressant for the prevention and treatment of organ transplant rejection. The target of rapamycin is called TOR (Target of Rapamycin), which is an atypical serine / t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07H17/00C07H15/207C07H1/06C12P19/60C12P19/18C12P19/46A61P35/00A61P31/10A01N43/90A01P3/00
CPCA01N43/90A61P31/10A61P35/00C07H1/06C07H15/207C07H17/00C12P19/18C12P19/46C12P19/60
Inventor 李越中张鹏张礼娟吴长生汤亚杰
Owner SHANDONG UNIV